Skip to main content
TES-Therapie bei Retinitis pigmentosa: OkuStim® 2

OkuStim® 2

The innovation for preserving vision in retinitis pigmentosa

OkuStim®2:
A user‑friendly
device

Proven and patented solutions for precise electrical stimulation of the eye and an ergonomic, award-winning design ensure the safe and simple use of the OkuStim® therapy at home.

OkuStim® 2 bei Retinitis pigmentosa: OkuEl® M

OkuEl® M:

The hair-thin electrodes are securely, hygienically and contact-free attached to the OkuStim® 2 using a patented magnetic connection.

Electrode holder:

The patented mechanism guides the electrodes individually to the eyes and holds them in place. The positioning can be easily adjusted to the patient’s individual facial shape.

OkuStim® 2 bei Retinitis pigmentosa: Elektrodenhalter
OkuStim® 2 bei Retinitis pigmentosa: Neurostimulator

OkuStim® 2, the neurostimulator:

The stimulation strength, individually defined for each patient, is stored directly on the OkuStim® 2. The treatment is started at home with the press of a button.

Designed for new perspectives

For further information on the OkuStim® 2, please refer to the instructions for use.

View instructions for use
OkuStim® 2 bei Retinitis pigmentosa: OkuEl® M am Auge einer Person
Changing the
course

A genuine opportunity for those affected to slow visual field loss is transcorneal electrical stimulation (TES) with OkuStim® 2 – the only CE-marked medical device for the treatment of retinitis pigmentosa.

During OkuStim® therapy, weak electrical impulses pass through the cornea into the eye. They spread intraocularly and polarise the retinal signalling pathways. This aims to activate neuroprotective processes that slow the progression of the disease and may prevent or delay later stages of retinitis pigmentosa. The earlier therapy starts, the better.

Learn more about the therapy

Easy to use

OkuStim® is designed so that patients can quickly learn to use it and perform the treatment independently at home. The therapy is applied once a week for 30 minutes. OkuStim® is available by prescription only. Please consult your physician before use and read the complete instructions for use. Below is a brief overview of the procedure:

1

Take the OkuStim® 2 out of its packaging and switch it on. Press the on/off button for at least 2 seconds. Insert the OkuEI® M into the electrode holder of the OkuStim® 2.

Anwendung der TES-Therapie mit dem OkuStim® 2 – Schritt 1: Einschalten des Geräts
Anwendung der TES-Therapie mit dem OkuStim® 2 – Schritt 2: Aufsetzen des OkuStim® 2

2

Take a comfortable and stable sitting position. Put on the OkuStim® 2 device.

3

Connect the OkuEI® M counter electrodes to the cables on the OkuStim® 2. Swing the electrode holders into position using the rotary handles and start the stimulation by pressing the Start/Pause button on the right side of the OkuStim® 2.

Anwendung der TES-Therapie mit dem OkuStim® 3 – Schritt 3: Verbinden der OkuEl® M mit den Kabeln
Anwendung der TES-Therapie mit dem OkuStim® 2 – Schritt 4: 30 Minuten Anwendung von zu Hause

4

It is recommended to keep your eyes closed during stimulation. The stimulation automatically stops after 30 minutes.

Our motivation

Everything we do is guided by one goal: to preserve the vision of people with degenerative retinal diseases for as long as possible. With innovative technology, we create new perspectives for those affected: our OkuStim® therapy can slow the progression of visual field loss in patients with retinitis pigmentosa, helping to delay serious impairments caused by vision loss.
We are proud that with OkuStim® 2, we have not only created a medical device but also a unique opportunity for everyone affected by retinitis pigmentosa.

“What drives us? To preserve vision for as long as possible.”

Dr. Alfred Stett, CEO Okuvision GmbH

Okuvision GmbH – Dr. Alfred Stett, Geschäftsführer
Okuvision GmbH – Dr. Alfred Stett, Geschäftsführer
info@okuvision.de
Tel:+49 (0) 7121 1593 50